From: Entrevestor
Date: Sept. 23, 2024
Labour market conditions and working with institutional buyers were among the topics discussed in Halifax last week.
When life sciences entrepreneurs and investors gathered at the Halifax Convention Centre for this year’s BioPort Atlantic conference, they received a day and a half of advice from senior players in the industry, including on managing risk, finding talent and doing business with healthcare organizations.
This year marked the 23rd BioPort conference, which is organized by industry group Life Sciences Nova Scotia. This time, its theme was “Powered by Possibilities,” which organizers described as a reference to the potential of life sciences on the East Coast, with the right collaboration across the sector.
Here’s a look at three of the key topics at BioPort this year:
Risk management in life sciences looks different.
The complexity and potential dangers of implementing new technology in healthcare systems can make decision-makers at those organizations more risk-averse than other fields of innovation. Often, companies must walk a fine line between managing risk and maintaining the viability of their businesses, particularly where manufacturing is involved. In healthcare more than any other field, though, institutional buyers must be risk averse.